DRTB
The kind of tuberculosis that has developed resistance to the drugs used in the treatment of the disease is called DRTB (Drug Resistant Tuberculosis). There can be various reasons why someone is suffering from DRTB. The most common reason is that patients often don’t finish their course or stop taking the medicine once the symptoms reduce. The act of not completing the full course of drugs can make the bacteria resistant. Other reasons include spending a long duration of time with someone who is suffering from DRTB or visiting a country where DRTB is common. Taking a full course of low-quality drugs can also lead to DRTB. The best way to prevent letting a DSTB turn into DRTB is to follow the instructions of the doctor carefully and take a complete course as prescribed by the doctor until the disease is completely treated.
Asia-Pacific Leads the Fight: Effective Solutions for Global TB Control
Communicable Diseases on the Move: TB and the Science of Epidemiology
The Unseen Struggle: Addressing TB Health Needs of India’s Internal Migrants
Innovative Approaches to TB Vaccination in Low-Resource Environments
Harnessing Technology for TB Prevention in Resource-Constrained Areas
Community Health Initiatives Fighting Tuberculosis Together
The Science Behind Tuberculosis: Understanding the Pathogen
Innovative Methods for Treating Latent Tuberculosis Infection
TB and Migration in India: Addressing the Health Needs of Migrant Workers
The Rise of the Superbug: Drug-Resistant TB and Its Consequences
The Economic Burden of TB: How the Disease Affects Individuals and Societies
Beyond the Lungs: How Tuberculosis Affects the Body and Mind
TB and Occupational Health: Protecting Workers in the World
Tuberculosis and the Virome: Exploring the Role of Viruses in TB Pathogenesis and Treatment
Tuberculosis and the Lung Microbiome: Unraveling the Complex Interplay
Digital Health Technologies in Tuberculosis Care
Tuberculosis Biomarkers: Advanced Early Detection and Treatment Monitoring
New TB Medicines and Regimens: Responsible Use for MDR-TB Treatment
The Importance of Contact Tracing in Tuberculosis Control
Experts Developing Immune-Enhancing Therapies to Treat TB